Lipid Controls
Avanti Polar Lipids SOY L-A-PHOSPHATIDYLSERI 500MG
L-α-phosphatidylserine (Soy, 99%) (sodium salt)5 x 100mg
Echelon Biosciences Research Labs PC Lipid Microparticles, 100 uL
PC Lipid Microparticles, 100 uL. This item is non returnable
Avanti Polar Lipids 18:1 PI(3,4)P2 1,2-DIOLEOYL-SN
18:1 PI(3,4)P2 1,2-dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4'-bisphosphate) (ammonium salt) 100ug
Avanti Polar Lipids 18:1 Lyso PC, 19420-56-5, MFCD00133435, powder, 25mg
Molecular Formula C26H52NO7P, Purity >99% LPC; may contain up to 10% of the 2-LPC isomer, Formula Weight 521.667, Synonyms: 1-oleoyl-2-hydroxy-sn-glycero-3-phosphocholine
![Avanti Polar Lipids 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt), 474922-77-5, MFCD02262268, 25 mg](https://assets.fishersci.com/TFS-Assets/CCG/product-images/VN00037649-C2618-200UL.PNG-250.jpg)
Avanti Polar Lipids 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt), 474922-77-5, MFCD02262268, 25 mg
Formula Weight: 2805.497, Purity >99%, Storage Temperature: -20°C. PEG-modified lipids are typically added to phospholipid vesicles used for drug delivery to provide a steric coating on the surface of the membrane to hinder clearing of the particles by the reticuloendothelial system (RES). This prolongs the circulating plasma half-life of the drug. The plasma half-life of the drug can be "tuned" from several hours to days depending on the size of the PEG and fatty acids attached to the lipid anchor.
Avanti Polar Lipids 18:0-20:4 PI(3,5)P2 100UG
18:0-20:4 PI(3,5)P2, 1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',5'-bisphosphate) (ammonium salt) 100ug